Skip to main content

BLS Patient Care Standards

Clarification on oxygen delivery for COVID-19 Patient

Submission ID: 19


I just have a question in regards to oxygen treatment. With the recent memorandum it states that in all cases high flow oxygen delivery should be avoided unless via ETT/SGA. Does this mean we are no longer able to use a BVM for a patient who is severely short of breath when a high concentration/low flow masks with a submicron filter is no longer able to maintain an appropriate 02 saturation level?

Read more …Clarification on oxygen delivery for COVID-19 Patient

  • Hits: 432

BHP Webinar

Submission ID: 16



On a recent webinar Dr. Exley cited two examples of orders a BHP might give that should not be followed because they are out of the scope of practice. One was an ACP getting an order for Atropine for a cholinergic overdose.

My question is just to clarify this point...

Am I to conclude that if I have a patient exposed to Organophosphates or Carbamate or Herbicides who is experiencing severe S&S of a cholinergic OD (Hypotension, Bradycardia, SLUDGE), that I CANNOT contact a BHP and ask for Atropine or carry out the order if a BHP orders Atropine?

My confusion stems from a belief that I have always been able to perform this procedure and because the Medical Directive for Adult and Paediatric Nerve Agent Exposure calls for the administration of Atropine at given doses based on whether the patient's condition is moderate or severe:

Adult 2 - 6 mg

Ped. 0.5 - 1 mg/kg

I appreciate the time taken in providing me with an answer, and look forward to hearing from you.

Read more …BHP Webinar

  • Hits: 543

Nitro patch removal

Submission ID: 22


Hi there, I would like to inquire about whether or not there is a need to remove a patient’s Nitroglycerin transdermal patch prior to delivering Nitroglycerin SL under the Cardiac Ischemia or Acute Cardiogenic Pulmonary Edema Medical Directives. Much appreciated.

Read more …Nitro patch removal

  • Hits: 493